Neoadjuvant concurrent chemoradiotherapy combined with immunotherapy in the treatment of adenocarcinoma of the oesophagogastric junction: A phase II study

被引：0
|
作者：
Du, R. [1 ]
Ming, J. [1 ]
Geng, J. [1 ]
Sui, X. [1 ]
Li, S. [1 ]
Liu, Z. [1 ]
Zhu, X. [1 ]
Cai, Y. [1 ]
Wang, Z. [2 ]
Tang, L. [3 ]
Zhang, X. [4 ]
Peng, Z. [5 ]
Yan, Y. [6 ]
Li, Z. [7 ,8 ]
Peng, Y. [8 ]
Wu, A. [8 ]
Li, Y. [1 ]
Li, Z. [7 ,8 ]
Wang, W. [1 ]
Ji, J. [9 ]
机构：
[1] Beijing Canc Hosp & Inst, Radiat Oncol, Beijing, Peoples R China
[2] Beijing Canc Hosp & Inst, Med Imaging, Beijing, Peoples R China
[3] Peking Univ Canc Hosp & Inst, Radiol, Beijing, Peoples R China
[4] Peking Univ Canc Hosp & Inst, Gastrointestinal Oncol, Beijing, Peoples R China
[5] Peking Univ Canc Hosp & Inst, Key Lab Carcinogenesis & Translat Res, Minist Educ, Beijing, Peoples R China
[6] Beijing Canc Hosp & Inst, Endoscopy Ctr, Beijing, Peoples R China
[7] Beijing Canc Hosp & Inst, Pathol, Beijing, Peoples R China
[8] Beijing Canc Hosp & Inst, Surg Oncol, Beijing, Peoples R China
[9] Peking Univ Canc Hosp & Inst, Gastrointestinal Surg Dept, Beijing, Peoples R China
来源：
ANNALS OF ONCOLOGY | 2022年 / 33卷 / 07期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
1215P
引用
收藏
页码：S1104 / S1104
页数：1
相关论文
共 50 条
  • [1] Concurrent Neoadjuvant Chemoradiotherapy for Siewert II and III Adenocarcinoma at Gastroesophageal Junction
    Zhao, Qun
    Li, Yong
    Wang, Jun
    Zhang, Jun
    Qiao, Xueying
    Tan, Bibo
    Tian, Yuan
    Shi, Gaofeng
    Xu, Qian
    Li, Ruxun
    Liu, Yueping
    Yang, Peigang
    AMERICAN JOURNAL OF THE MEDICAL SCIENCES, 2015, 349 (06): : 472 - 476
  • [2] Neoadjuvant Toripalimab plus Concurrent Chemoradiotherapy in the Locally Advanced Adenocarcinoma of Esophagogastric Junction: A Phase II Trial
    Du, R.
    Geng, J.
    Liu, Z.
    Sui, X.
    Li, S.
    Tang, L.
    Wang, Z.
    Zhang, X.
    Yan, Y.
    Wu, A.
    Li, Z.
    Li, Y.
    Wang, W.
    Li, Z.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2024, 120 (02): : S48 - S48
  • [3] A phase II study of neoadjuvant concurrent chemoradiotherapy with apatinib for HER-2 negative Siewert type II and III adenocarcinoma of esophagogastric junction
    Zhao, Q.
    Wang, J.
    Guo, H.
    Li, Y.
    Lin, C.
    Cheng, Y.
    Zhang, Z.
    Wang, D.
    Zhao, X.
    Liu, Y.
    Jing, S.
    Yang, P.
    Tian, Y.
    Liu, Y.
    ANNALS OF ONCOLOGY, 2020, 31 : S902 - S902
  • [4] Establishment of prognostic models for adenocarcinoma of oesophagogastric junction patients with neoadjuvant chemoradiotherapy: a real-world study
    Du, Rongxu
    Ming, Jiao
    Geng, Jianhao
    Zhu, Xianggao
    Zhang, Yangzi
    Li, Shuai
    Liu, Zhiyan
    Wang, Hongzhi
    Wang, Zhilong
    Tang, Lei
    Zhang, Xiaotian
    Wu, Aiwen
    Bu, Zhaode
    Yan, Yan
    Li, Zhongwu
    Li, Yongheng
    Li, Ziyu
    Wang, Weihu
    RADIATION ONCOLOGY, 2022, 17 (01)
  • [5] Establishment of prognostic models for adenocarcinoma of oesophagogastric junction patients with neoadjuvant chemoradiotherapy: a real-world study
    Rongxu Du
    Jiao Ming
    Jianhao Geng
    Xianggao Zhu
    Yangzi Zhang
    Shuai Li
    Zhiyan Liu
    Hongzhi Wang
    Zhilong Wang
    Lei Tang
    Xiaotian Zhang
    Aiwen Wu
    Zhaode Bu
    Yan Yan
    Zhongwu Li
    Yongheng Li
    Ziyu Li
    Weihu Wang
    Radiation Oncology, 17
  • [6] Phase II study of sintilimab combined with FLOT regimen for neoadjuvant treatment of gastric or gastroesophageal junction (GEJ) adenocarcinoma
    Li Ning
    Li Zhi
    Fu Qiang
    Zhang Bin
    Zhang Jian
    Wan XiangBin
    Lu Chaomin
    Wang Jinbang
    Deng Wenying
    Wei Chen
    Ma Yijie
    Bie Liangyu
    Wang Mengyu
    Luo Suxia
    JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (03)
  • [7] Phase II study of sintilimab combined with FLOT regimen for neoadjuvant treatment of gastric or gastroesophageal junction (GEJ) adenocarcinoma
    Li, N.
    Li, Z.
    Fu, Q.
    Zhang, B.
    Zhang, J.
    Wan, X.
    Lu, C.
    Wang, J.
    Deng, W.
    Wei, C.
    Ma, Y.
    Bie, L.
    Wang, M.
    Luo, S.
    ANNALS OF ONCOLOGY, 2020, 31 : S1302 - S1302
  • [8] The Neo-PLANET phase II trial of neoadjuvant camrelizumab plus concurrent chemoradiotherapy in locally advanced adenocarcinoma of stomach or gastroesophageal junction
    Zhaoqing Tang
    Yan Wang
    Dan Liu
    Xuefei Wang
    Chen Xu
    Yiyi Yu
    Yuehong Cui
    Cheng Tang
    Qian Li
    Jing Sun
    Qian Zhang
    Yuan Ji
    Guifen Ma
    Haojie Li
    Zhenbin Shen
    Kuntang Shen
    Rongrong Zheng
    Zhiguo Hou
    Tianshu Liu
    Jiping Wang
    Yihong Sun
    Nature Communications, 13
  • [9] The Neo-PLANET phase II trial of neoadjuvant camrelizumab plus concurrent chemoradiotherapy in locally advanced adenocarcinoma of stomach or gastroesophageal junction
    Tang, Zhaoqing
    Wang, Yan
    Liu, Dan
    Wang, Xuefei
    Xu, Chen
    Yu, Yiyi
    Cui, Yuehong
    Tang, Cheng
    Li, Qian
    Sun, Jing
    Zhang, Qian
    Ji, Yuan
    Ma, Guifen
    Li, Haojie
    Shen, Zhenbin
    Shen, Kuntang
    Zheng, Rongrong
    Hou, Zhiguo
    Liu, Tianshu
    Wang, Jiping
    Sun, Yihong
    NATURE COMMUNICATIONS, 2022, 13 (01)
  • [10] Concurrent chemoradiotherapy combined with immunotherapy is superior to traditional concurrent chemoradiotherapy in the treatment of advanced cervical cancer
    Peng, Hsiu-Huei
    Wang, Yi-Lun
    Lin, Cheng-Tao
    EUROPEAN JOURNAL OF GYNAECOLOGICAL ONCOLOGY, 2019, 40 (01) : 36 - 39
12345